Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Objective This study compared the ability of glucagon to restore plasma glucose (PG) after mild hypoglycemia in patients with type 1 diabetes on an isocaloric high-carbohydrate diet (HCD) versus a low-carbohydrate diet (LCD). Research design and methods Ten patients with insulin pump-treated type 1 diabetes randomly completed 1 week of the HCD (≥250 g/day) and 1 week of the LCD (≤50 g/day). After each week, mild hypoglycemia was induced by a subcutaneous insulin bolus in the fasting state. When PG reached 3.9 mmol/L, 100 µg glucagon was given subcutaneously, followed by 500 µg glucagon 2 h later. Results Compared with the HCD, the LCD resulted in lower incremental rises in PG after the first (mean ± SEM: 1.3 ± 0.3 vs. 2.7 ± 0.4 mmol/L, P = 0.002) and second glucagon bolus (4.1 ± 0.2 vs. 5.6 ± 0.5 mmol/L, P = 0.002). No differences were observed between the diets regarding concentrations of insulin, glucagon, and triglycerides. Conclusions The LCD reduces the treatment effect of glucagon on mild hypoglycemia. Carbohydrate intake should be considered when low-dose glucagon is used to correct hypoglycemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In persons with T2D being treated with alpha-glucosidase inhibitors, who develop hypoglycemia due to use of hypoglycemic agents, oral glucose or lactose-containing foods (dairy products) must be given because alpha-glucosidase inhibitors inhibit the breakdown and absorption of complex carbohydrates and disaccharides.1218–1225”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1222]
Citations
Cites
CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
Ferrannini, E., Mark, M., & Mayoux, E. (2016) · Diabetes Care · doi:10.2337/dc16-0330 · Cited by 975
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725 · cited 1×
“In individuals with type 1 diabetes, hypoglycemia is a barrier for achieving optimal glycemic control (1).”
BackgroundIntense Exercise Has Unique Effects on Both Insulin Release and Its Roles in Glucoregulation
Marliss, E. B., & Vranic, M. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s271 · Cited by 390
Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis
Deary, I. J., Hepburn, D. A., MacLeod, K. M., & Frier, B. M. (1993) · Diabetologia · doi:10.1007/bf00401150 · Cited by 286
Glucagon physiology and pathophysiology
Sherwood, L. M., Parris, E. E., & Unger, R. H. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108192850806 · Cited by 267 · cited 1×
“with the HCD, which may be caused by an increased intakeof protein combinedwith insulin-independent reduction of the glucose during the LCD (14,15).”
BackgroundHaidar, A., Legault, L., Messier, V., Mitre, T. M., Leroux, C., & Rabasa-Lhoret, R. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70226-8 · Cited by 214 · cited 1×
“However, glucagon treatment cannot eliminate all hypoglycemic events (4).”
BackgroundRussell, S. J., Hillard, M. A., Balliro, C., Magyar, K. L., Selagamsetty, R., Sinha, M., Grennan, K., Mondesir, D., Ekhlaspour, L., Zheng, H., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00489-1 · Cited by 179 · cited 1×
“Low doses of glucagon can effectively treat hypoglycemia (2) and even reduce the risk of hypoglycemia by automated insulin-glucagon delivery systems (3).”
BackgroundFat and carbohydrate balances during adaptation to a high-fat diet
Smith, S. R., de Jonge, L., Zachwieja, J. J., Roy, H. J., Nguyen, T., Rood, J. C., WINDHAUSER, M. M., & Bray, G. A. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.2.450 · Cited by 131
Mini-Dose Glucagon Rescue for Hypoglycemia in Children With Type 1 Diabetes
Haymond, M. W., & Schreiner, B. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.643 · Cited by 114 · cited 1×
“Glucagon may be used as an add-on to insulin in open-loop (18) and closed-loop settings (19).”
BackgroundBischof, M. G., Krssak, M., Krebs, M., Bernroider, E., Stingl, H., Waldhäusl, W., & Roden, M. (2001) · Diabetes · doi:10.2337/diabetes.50.2.392 · Cited by 90 · cited 1×
“The LCD has been shown to reduce hepatic glycogen stores in healthy individuals (10) and may be similar in individuals with type 1 diabetes (11).”
Background
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Smart, C. E., Annan, F., Higgins, L. A., Jelleryd, E., Lopez, M., & Acerini, C. L. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12738 · Cited by 230
“of hypoglycemia or potentially impair the effect of glucagon in hypoglycemia treatment.(33) It is important to respectfully explore the family’s reasons for”
Glucagon Receptor Signaling and Glucagon Resistance
Janah, L., Kjeldsen, S., Galsgaard, K. D., Winther-Sørensen, M., Stojanovska, E., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133314 · Cited by 203
“This indicates that the LCD may have promoted the use of fat over carbohydrates, resulting in increased fat oxidation and ketogenesis [99], supporting the conclusion that glucagon regulates glucose homeostasis mainly through glycogenolysis rather than gluconeogenesis.”
BackgroundSelf-citationSievenpiper, J. L., Chan, C. B., Dworatzek, P. D., Freeze, C., & Williams, S. L. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.009 · Cited by 200
The Liver–α-Cell Axis and Type 2 Diabetes
Wewer Albrechtsen, N. J., Pedersen, J., Galsgaard, K. D., Winther-Sørensen, M., Suppli, M. P., Janah, L., Gromada, J., Vilstrup, H., Knop, F. K., & Holst, J. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00251 · Cited by 149
Self-citationAnnan, S. F., Higgins, L. A., Jelleryd, E., Hannon, T., Rose, S., Salis, S., Baptista, J., Chinchilla, P., & Marcovecchio, M. L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13429 · Cited by 143
Ranjan, A., Schmidt, S., Damm‐Frydenberg, C., Holst, J. J., Madsbad, S., & Nørgaard, K. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12953 · Cited by 101
Self-citationSeckold, R., Fisher, E. L., de Bock, M. I., King, B. R., & Smart, C. E. (2018) · Diabetic Medicine · doi:10.1111/dme.13845 · Cited by 108
Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges
Vilarrasa, N., San Jose, P., Rubio, M. Á., & Lecube, A. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s223618 · Cited by 88
Schmidt, S., Christensen, M. B., Serifovski, N., Damm‐Frydenberg, C., Jensen, J. B., Fløyel, T., Størling, J., Ranjan, A. G., & Nørgaard, K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13725 · Cited by 84
“4) kg/m(2), diabetes duration 19 (13-32) years, HbA1c 58 (55-60) mmol/mol [7.”
Self-citationScott, S. N., Anderson, L., Morton, J. P., Wagenmakers, A. J. M., & Riddell, M. C. (2019) · Nutrients · doi:10.3390/nu11051022 · Cited by 73
“raised concern for VLCDs in people with T1D in a study that demonstrated that one week of an isocaloric VLCD, defined as ≤50 g per day, reduced the treatment effect of glucagon given to treat mild hypoglycaemia [35].”
BackgroundInfluentialMulla, C. M., Zavitsanou, S., Laguna Sanz, A. J., Pober, D., Richardson, L., Walcott, P., Arora, I., Newswanger, B., Cummins, M. J., Prestrelski, S. J., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz197 · Cited by 43
Adaptive model predictive control for a dual-hormone artificial pancreas
Boiroux, D., Bátora, V., Hagdrup, M., Wendt, S. L., Poulsen, N. K., Madsen, H., & Jørgensen, J. B. (2018) · Journal of Process Control · doi:10.1016/j.jprocont.2018.05.003 · Cited by 46
Revolutionizing drug delivery: The power of stimulus-responsive nanoscale systems
Hu, S., Zhao, R., Shen, Y., & Lyu, B. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154265 · Cited by 41
‘Old Is Gold’: How Traditional Indian Dietary Practices Can Support Pediatric Diabetes Management
Salis, S. S., Virmani, A., Priyambada, L., Mohan, M., Hansda, K., & de Beaufort, C. E. (2021) · Nutrients · doi:10.3390/nu13124427 · Cited by 44
“Although low carbohydrate diets are sometimes attempted to improve glycemic control, they can be nutritionally inadequate, impair growth and development, increase the risk of disordered eating behaviors, increase hypoglycemia or potentially impair the effect of glucagon in hypoglycemia, and increase cardiovascular ris…”
Background(2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.04.001 · Cited by 42
Tian, W., Cao, S., Guan, Y., Zhang, Z., Liu, Q., Ju, J., Xi, R., & Bai, R. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1516086 · Cited by 42
New uses and formulations of glucagon for hypoglycaemia
Beato-Víbora, P. I., & Arroyo-Díez, F. J. (2019) · Drugs in Context · doi:10.7573/dic.212599 · Cited by 40
Róg, J., Wingralek, Z. J., Nowak, K., Grudzień, M., Grunwald, A., Banaszek, A., & Karakuła‐Juchnowicz, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102819 · Cited by 35
“According to a study by Shamshoum et al., fasting or short-term ingestion of a KD protects against OLZ-induced hyperglycemia, regardless of changes in whole-body activity of insulin, and is associated with a reduced rise in serum glucagon [54,58–60].”
ResultAntoniotti, V., Spadaccini, D., Ricotti, R., Carrera, D., Savastio, S., Correia, F. P. G., Caputo, M., Pozzi, E., Bellone, S., Rabbone, I., et al. (2022) · Nutrients · doi:10.3390/nu14030596 · Cited by 32
“In addition, there is evidence that low-carbohydrate diets can be nutritionally inadequate and may increase the risk of hypoglycemia [9].”
BackgroundPrins, P., Noakes, T. D., Buga, A., Gerhart, H. D., Cobb, B. M., D’Agostino, D. P., Volek, J. S., Buxton, J. D., Heckman, K., Plank, E. N., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00583.2024 · Cited by 31
Glucagon: Its evolving role in the management of hypoglycemia
Isaacs, D. M., Clements, J. N., Turco, N., & Hartman, R. (2021) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2534 · Cited by 31
Steineck, I. I. K., Ranjan, A. G., Schmidt, S., Clausen, T. R., Holst, J. J., & Nørgaard, K. (2019) · Diabetologia · doi:10.1007/s00125-018-4807-8 · Cited by 27
Self-citationLow-Carbohydrate Diet among Children with Type 1 Diabetes: A Multi-Center Study
Neuman, V., Plachý, L., Průhová, Š., Koloušková, S., Petruželková, L., Obermannová, B., Vyzralkova, J., Konečná, P., Vosáhlo, J., Romanová, M., et al. (2021) · Nutrients · doi:10.3390/nu13113903 · Cited by 26
“On top of that, it might be that the patients on the LCD are at increased risk of severe hypoglycemia as their response to glucagon is blunted [20].”
BackgroundConsuming a ketogenic diet leads to altered hypoglycemic counter-regulation in mice
Morrison, C. D., Hill, C. M., DuVall, M. A., Coulter, C. E., Gosey, J. L., Herrera, M. J., Maisano, L. E., Sikaffy, H. X., & McDougal, D. H. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107557 · Cited by 25
Role of Glucagon in Automated Insulin Delivery
Wilson, L. M., Jacobs, P. G., & Castle, J. R. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.008 · Cited by 25
Weight Management in Youth with Type 1 Diabetes and Obesity: Challenges and Possible Solutions
Zaharieva, D. P., Addala, A., Simmons, K. M., & Maahs, D. M. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00411-z · Cited by 21
Medical management of children with type 1 diabetes on low‐carbohydrate or ketogenic diets
Rydin, A., Spiegel, G., Frohnert, B. I., Kaess, A., Oswald, L., Owen, D., & Simmons, K. M. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13179 · Cited by 19
“restriction of carbohydrates, there is an increased risk of hypoglycemia, and this may be due in part to increased hypoglycemia unawareness and a decreased response to glucagon.(14,25) Therefore, intensive glucose monitoring of ≥6 times/day or alternatively wearing a CGM is recommended in the protocol.”
BackgroundRanjan, A. G., Nørgaard, K., Tetzschner, R., Steineck, I. I. K., Clausen, T. R., Holst, J. J., Madsbad, S., & Schmidt, S. (2018) · Diabetes Care · doi:10.2337/dc17-1458 · Cited by 17
“Finally, 1 week of a low-carbohydrate diet may also impair the effect of glucagon to restore plasma glucose (27).”
BackgroundMethodSelf-citationThe glucose-mobilizing effect of glucagon at fasting is mediated by cyclic AMP
Albrechtsen, N. J. W. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00172.2021 · Cited by 18
The kinetics of glucagon action on the liver during insulin-induced hypoglycemia
Pedersen, C., Kraft, G., Edgerton, D. S., Scott, M. F., Farmer, B., Smith, M. S., LaNeve, D. C., Williams, P. E., Moore, L. M., & Cherrington, A. D. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00466.2019 · Cited by 14
Nutrition and Exercise Performance in Adults With Type 1 Diabetes
Colberg, S. R. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.05.014 · Cited by 18
Shamshoum, H., Medak, K. D., McKie, G. L., Hahn, M., & Wright, D. C. (2022) · The Journal of Physiology · doi:10.1113/jp282922 · Cited by 14
“Edwards et al., 1969; Ikeda et al., 1987; Morrison et al., 2020; Ranjan et al., 2017), providing evidence that interventions such as fasting or the consumption of ketogenic diets (KDs) might be effective approaches to mitigate AP-induced excursions in blood glucose.”
BackgroundGlucagon for hypoglycaemia treatment in type 1 diabetes
Ranjan, A. G., Schmidt, S., & Nørgaard, K. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3409 · Cited by 17
“12 weeks of low carbohydrate diet compared with a higher carbohydrate diet.(88,89) Even though the glucose response was attenuated,”
MethodSelf-citationLega, I. C., Yale, J.-F., Chadha, A., Paty, B., Roscoe, R., Snider, M., Steier, J., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.08.003 · Cited by 12
“In individuals on a low-carbohydrate diet, the treat-ment effect of glucagon may be reduced [135].”
BackgroundA Case of Hypoglycemia Associated With the Ketogenic Diet and Alcohol Use
Spoke, C., & Malaeb, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa045 · Cited by 12
“Ketogenetic diets have been associated with nausea, vomiting, dehydration, and hypoglycemia in the short term, while longer-term effects include disrupted lipid metabolism, hepatic steatosis, hypoproteinemia, mineral deficiency, and nephrolithiasis [16-18].”
BackgroundPedersen, C., Bouman, S. D., Porsgaard, T., ROSENKILDE, M. M., & Roed, N. K. (2018) · Physiological Reports · doi:10.14814/phy2.13657 · Cited by 12
Neuman, V., Plachý, L., Drnkova, L., Pruhova, S., Kolouskova, S., Obermannova, B., Amaratunga, S. A., Maratova, K., Kulich, M., Havlik, J., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111844 · Cited by 10
Evaluating dasiglucagon as a treatment option for hypoglycemia in diabetes
Li, S., Hu, Y., Tan, X., Wang, D., Hu, J., Zou, P., & Wang, L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1747432 · Cited by 11
Dietary guidelines in diabetes – why are they so difficult to follow?
Sińska, B. I., & Kucharska, A. (2023) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.5114/pedm.2023.132024 · Cited by 9
Low-carbohydrate diets in type 1 diabetes: balancing benefits and risks
Hancock, M., Burns, K. A., Gan, S. K., & Chew, G. T. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000797 · Cited by 10
“LCDs are demonstrated to reduce glycogen stores, and reduced secretion of adrenaline and response to glucagon in the setting of hypoglycaemia is observed [23,24].”
BackgroundRuddiman, K. R., Bartfield, J. K., & Hirsch, I. B. (2025) · Obesity · doi:10.1002/oby.70033 · Cited by 10
“However, there is not yet sufficient evidence to recommend the safety of a ketogenic diet in T1D, with ongoing concerns for the risk of hypoglycemia, reduced glycogen stores blunting the response to glucagon [38], and the risk of relative insulin deficiency leading to DKA [39].”
Winje, E., Lake, I., & Dankel, S. N. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1404842 · Cited by 7
Furió-Novejarque, C., Sanz, R., Ritschel, T. K. S., Reenberg, A. T., Ranjan, A. G., Nørgaard, K., Díez, J.-L., Jørgensen, J. B., & Bondía, J. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106605 · Cited by 7
Self-citationUnfavorable Effects of Low-carbonhydrate Diet in a Pediatric Patient with Type 1 Diabetes Mellitus
Güleryüz, C., Eker, E., Küçükali, G. K., Şakar, M., Genç, F. N., Şahin, N. M., Elmaoğulları, S., Çetinkaya, S. Ç., & Erdeve, Ş. S. (2022) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2021.2021-10-18 · Cited by 7
“There are also studies showing that feeding with KD increases the risk of hypoglycemia and impairs the effectiveness of glucagon used in the treatment of hypoglycemia (10).”
BackgroundWoodburn, E. V., & Rostykus, P. S. (2019) · The Journal of Collegiate Emergency Medical Services · doi:10.30542/jcems.2019.02.01.02 · Cited by 6
Nedoboy, P. E., Cohen, E. M., & Farnham, M. M. J. (2021) · Nutrients · doi:10.3390/nu13082627 · Cited by 5
“For that reason, and the fact that glucagon injections are less effective in patients who follow a low-carbohydrate diet [22], our study focused specifically on the role of the sympathoadrenal system and epinephrine, which are expected to be the major contributors to the CRR in the setting of type 1 diabetes.”
BackgroundRanjan, A. G., Wendt, S. L., Schmidt, S., Madsbad, S., Holst, J. J., Madsen, H., Knudsen, C., Jørgensen, J. B., & Nørgaard, K. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12907 · Cited by 5
Self-citationLow-Carb and Ketogenic Diets in Type 1 Diabetes: Efficacy and Safety Concerns
Korakas, E., Kountouri, A., Petrovski, G., & Lambadiari, V. (2025) · Nutrients · doi:10.3390/nu17122001 · Cited by 6
“In one study, individuals on an LCD exhibited a blunted glycemic response to glucagon during insulin-induced hypoglycemia [47].”
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2020) · Diabetologie und Stoffwechsel · doi:10.1055/a-1245-5623 · Cited by 4
“[170] Ranjan A, Schmidt S, Damm-Frydenberg C et al.”
BackgroundTetzschner, R., Ranjan, A. G., Schmidt, S., & Nørgaard, K. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-00696-x · Cited by 4
Self-citationKusumastuty, I., Handayani, D., Tjahjono, H. A., Sari, E. P., Rahayuningtyas, S. K., & Saputra, A. B. (2021) · Amerta Nutrition · doi:10.20473/amnt.v5i1.2021.41-51 · Cited by 5
Cury, J. C. S., Encinas, J. F. A., Nucci, R. A. B., Ornelas, E., Lima, N. E. A., Braggion, G. F., Alves, B. D. C. A., da Veiga, G. L., Fonseca, F. L. A., & Maifrino, L. B. M. (2019) · Comparative Clinical Pathology · doi:10.1007/s00580-019-03022-w · Cited by 3
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2021) · Diabetologie und Stoffwechsel · doi:10.1055/a-1515-8766 · Cited by 3
Neuman, V., Maratová, K., Plachý, L., Drnkova, L., Průhová, Š., Koloušková, S., Obermannová, B., Amaratunga, S. A., Kulich, M., Havlík, J., et al. (2025) · European Journal of Clinical Nutrition · doi:10.1038/s41430-025-01658-2 · Cited by 2
“…of nutrient intake and possible associated risks including blunted response to glucagon possibly increasing the risk for severe hypoglycemia [6], disturbance of blood lipid pro fi le [7], increased risk of eating behavior disorders [8, 9], fatigue [7] or decreasing growth velocity [7] [10],…”
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1908-0685 · Cited by 2
Furió-Novejarque, C., Sala-Mira, I., Ranjan, A. G., Nørgaard, K., Díez, J.-L., Jørgensen, J. B., & Bondía, J. (2023) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2023.10.275 · Cited by 2
Self-citationNutritional Recommendations for People with Type 1 Diabetes Mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2500-0477 · Cited by 2
“The effectiveness of emergency glucagon is also re - duced due to the lower liver glycogen content [102].”
Tip 1 Diyabetli Bireylerin Yiyecek İçecek İşletmelerinden Beklentileri Üzerine Bir Araştırma
Gürkan, A. S., & Ulema, Ş. (2020) · Turk Turizm Arastirmalari Dergisi · doi:10.26677/tr1010.2020.589 · Cited by 2
Nutritional Recommendations for People with Type 1 Diabetes Mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2020) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1284-6036 · Cited by 2
DuVall, M. A., Coulter, C. E., Gosey, J. L., Herrera, M. J., Hill, C. M., Jariwala, R. R., Maisano, L. E., Moldovan, L. A., Morrison, C. D., Nwabueze, N. V., et al. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102853 · Cited by 2
Obesity in Type 1 Diabetes Mellitus
Kalkan, G. E., & Özcan, B. A. (2023) · Wiley eBooks · doi:10.1002/9781119983347.ch9 · Cited by 2
Depolarization of coherent backscattering
Kuzmin, V. L., Romanov, V. P., & Kuzmin, L. V. (1992) · Optics and Spectroscopy · Cited by 2
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01040-5 · Cited by 1
“Auch die Wirksamkeit von Notfall-Glukagon ist infolge des geringeren Lebergehalts an Glykogen herabgesetzt [139].”
Zhen, X. M., Purcell, A. R., Glastras, S. J., Twigg, S., & Wong, J. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104641 · Cited by 1
Holt, R. I. G., DeVries, J. H., Fischl, A. H., Hirsch, I. B., Kirkman, M. S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, É., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06833-z · Cited by 1
Self-citationTip 1 Diyabetli Çocuk ve Adölesanların Beslenme Sorunlarına Yaklaşım ve Yetişkin Kliniğe Devri
Altınok, Y. A. (2019) · Journal of Nutrition and Dietetics · doi:10.33076/2019.bdd.1315 · Cited by 3
“Bunun yanı sıra düşük karbonhidrat alımı hipoglisemi riskini artırabilir veya glukagonun hipoglisemi tedavisindeki etkisine potansiyel olarak zarar verebilir (30).”
BackgroundLaugesen, C., Schmidt, S., Holst, J. J., Nørgaard, K., & Ranjan, A. G. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14301 · Cited by 1
Self-citationTipici, B. E., Altınok, Y. A., & Keser, A. (2022) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2022.2022-6-4 · Cited by 1
Low-Carbohydrate Diets and Glycaemic Control in Type 1 Diabetes Mellitus
Diamond, M., & Clark, E. (2018) · EMJ Diabetes · doi:10.33590/emjdiabet/10313261 · Cited by 3
Nutritional Recommendations for People with Type 1 Diabetes Mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1946-3753 · Cited by 2
Klatka, M., Kozyra, K., Pola, A., & Rysz, I. (2016) · Pediatric Endocrinology Diabetes and Metabolism · doi:10.18544/pedm-22.04.0067
Strategies to mitigate hypoglycaemia in the artificial pancreas
Bondía, J., & Vehí, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815655-1.00018-1
Ranjan, A. G., Schmidt, S., Holst, J. J., Christensen, M. B., & Nørgaard, K. (2020) · medRxiv · doi:10.1101/2020.10.30.20222794
Self-citationEmpfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00749-5
Empfehlungen zur Ernährung von Personen mit Diabetes mellitus Typ 1
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00910-8
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., Skurk, T., & für den Ausschuss Ernährung der, D. D. G. (2023) · Diabetologie und Stoffwechsel · doi:10.1055/a-1997-7789 · Cited by 1
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2024) · Diabetes aktuell · doi:10.1055/a-2248-5316
Furió-Novejarque, C. (2024) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/202872
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01172-2
“Auch die Wirksamkeit von Notfall-Glukagon ist infolge des geringeren Lebergehalts an Glykogen herabgesetzt [102].”
Andreozzi, F., Mancuso, E., Rubino, M., Salvatori, B., Morettini, M., Monea, G., Göbl, C. S., Mannino, G. C., & Tura, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376530
Analysis on the contribution of glucagon receptors to glucose dynamics in type 1 diabetes
Furió-Novejarque, C., Sala-Mira, I., Ranjan, A. G., Nørgaard, K., Díez, J.-L., Jørgensen, J. B., & Bondía, J. (2024) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2024.100272
Self-citationEmpfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2311-9952
Treatment of Obesity in Individuals with Type 1 Diabetes
Almehthel, M. S., & Alshehri, A. (2024) · Canadian Diabetes & Endocrinology Today · doi:10.58931/cdet.2024.2332
Ketogenic Metabolic Therapy as a Treatment for Mental Health Disorders
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6338-0
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01339-5
Restrição de hidratos de carbono na diabetes tipo 1
Bento, A. C. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/fnv4-1p70
Gros, P. (2024) · Repository of the University of Primorsk (University of Primorska)
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D. F., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-8166
Empfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus
Rubin, D. F., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01471-w
SCHMIDT, S., Kristensen, K. B., McCarthy, O. M., Bracken, R. M., Holst, J. J., Nørgaard, K., & Ranjan, A. G. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70777
“We have previously shown that the efficacy of low-dose glucagon in treating insulin-induced hypoglycemia was diminished after 7 days of low carbohydrate intake (< 50 g/day) compared with a high intake (> 250 g/day) [3].”
Self-citationEmpfehlungen zur Ernährung von Personen mit Typ-1-Diabetes mellitus – Praxisempfehlung der DDG
Rubin, D. F., Bosy‐Westphal, A., Kabisch, S., Kronsbein, P., Müssig, K., Simon, M., Tombek, A., Weber, K. S., & Skurk, T. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2874-4204
Metadata
- Authors
- Ranjan, A., Schmidt, S., Damm-Frydenberg, C., Steineck, I., Clausen, T. R., Holst, J. J., Madsbad, S., & Nørgaard, K.
- Affiliations
- Hvidovre Hospital (DK)
- Department of Endocrinology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark
- Novo Nordisk (Denmark) (DK)
- University of Copenhagen (DK)
- Corresponding author
- Ranjan, Ajenthen
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-10-21
- Volume
- 40
- Issue
- 1
- Pages
- 132-135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2536220037
- Cited by
- 89
- References
- 19
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 11 · 2023: 9 · 2022: 8 · 2021: 11 · 2020: 13 · 2019: 14 · 2018: 7 · 2017: 2
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Danish Diabetes Academy
- Danish Diabetes Association
- Poul and Erna Sehested Hansen Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- low-carbohydrate diet, glucagon, mild hypoglycemia, type 1 diabetes, high-carbohydrate diet, plasma glucose, insulin-induced hypoglycemia, glucagon response, carbohydrate intake, insulin pump therapy
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Fasting, Female, Glucagon, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Cross-Over Studies, Diet, Carbohydrate-Restricted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.